Tarceva (erlotinib tablets - Genentech, generic) — Cigna
Pancreatic Cancer
Initial criteria
- Patient is age ≥ 18 years
- Patient has locally advanced, metastatic, or recurrent disease
- The medication is used in combination with gemcitabine
Approval duration
1 year